11/08/2015 - 19:47
VANCOUVER, B.C. – Each of the newer classes of antidiabetic medications – the DPP-IV inhibitors, GLP-1 agonists, and SGLT2 inhibitors – has its own characteristic cutaneous side effects, Dr. Justin...
Field of Interest: Dermatology
News Feed: Internal Medicine News - Dermatology